Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2–Dependent Manner
- 3 February 2023
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 193 (5) , 624-637
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA229431)
This publication has 34 references indexed in Scilit:
- New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer CellsPLOS ONE, 2013
- Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitroExperimental Cell Research, 2013
- A Targeted Library Screen Reveals a New Inhibitor Scaffold for Protein Kinase DPLOS ONE, 2012
- Inducible Silencing of Protein Kinase D3 Inhibits Secretion of Tumor-Promoting Factors in Prostate CancerMolecular Cancer Therapeutics, 2012
- PKD2 and PKD3 Promote Prostate Cancer Cell Invasion via uPA by Shifting Balance Between NF-κB and HDAC1Journal of Cell Science, 2012
- A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer GrowthIn vitroandIn vivoMolecular Cancer Therapeutics, 2010
- Protein Kinase D1 Inhibits Cell Proliferation through Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Secretion in Prostate CancerCancer Research, 2010
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesionsOncogene, 2009
- Potent and Selective Disruption of Protein Kinase D Functionality by a BenzoxoloazepinoloneJournal of Biological Chemistry, 2008
- Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with boneCancer and Metastasis Reviews, 2006